Molnlycke Health Care AB - Strategic SWOT Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI's, and Recent Trends
Company Report I 2025-06-20 I 74 Pages I Quaintel Research
Report Summary
Molnlycke Health Care AB - Strategic SWOT Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI's, and Recent Trends is a comprehensive and easily accessible overview of Molnlycke Health Care AB 's business operations. It provides a detailed analysis of the company's strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Molnlycke Health Care AB including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Molnlycke Health Care AB's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. By integrating these strategic analyses, the report offers a comprehensive understanding of Molnlycke Health Care AB's overall strategic standing and supports informed decision-making and strategic planning.
Finally, the report includes recent news and deal activities undertaken by Molnlycke Health Care AB enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
Molnlycke Health Care AB, founded in 1849, is a world-leading MedTech company headquartered in Molndal, Sweden. With a legacy of over 175 years, the company has consistently driven innovation to improve patient outcomes and healthcare efficiency while reducing environmental impact. Molnlycke operates globally, with commercial entities in multiple countries and a presence in over 100 markets worldwide. The company's operations are supported by several manufacturing sites and thousands of employees committed to advancing healthcare.
Molnlycke is structured around four key business areas: Wound Care, Operating Room Solutions, Gloves, and Antiseptics. Among these, Wound Care represents the largest segment, accounting for 59% of the company's total sales in 2024. The company provides a range of effective and sustainable medical solutions, including advanced wound dressings, surgical equipment, antiseptic products, and innovative gloves. Molnlycke's mission is to revolutionize care for both people and the planet, combining clinical excellence with a strong focus on environmental responsibility.
Molnlycke Health Care AB in the News:-
- 21-May-2025 - Molnycke Health Care inaugurates new global headquarters at GoCo Health Innovation City
- 13-May-2025 - Molnlycke Health Care's long-term target to reach net zero emissions validated by Science Based Targets initiative
- 01-Apr-2025 - Molnlycke Health Care publishes Annual report for 2024
- 28-Mar-2025 - New study demonstrates the potential benefits of dressing regime improvements in delivering value-based chronic wound care
- 25-Feb-2025 - Molnlycke Health Care announces launch of the 2025 Future Summit
Scope
- Tactical Analysis:- Various strategic frameworks to gain insights into a Molnlycke Health Care AB's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the Molnlycke Health Care AB's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Company Fundamentals:- These fundamentals offer valuable insights into the Molnlycke Health Care AB's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the Molnlycke Health Care AB's main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
- Comprehensive Understanding of the Molnlycke Health Care AB's internal and external factors through SWOT analysis and Corporate Strategy.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company Molnlycke Health Care AB:
- Molnlycke Health Care AB PESTLE Analysis
- Molnlycke Health Care AB Value Chain Analysis
- Molnlycke Health Care AB Porter's Five Forces Analysis
- Molnlycke Health Care AB VRIO Analysis
- Molnlycke Health Care AB BCG Analysis
- Molnlycke Health Care AB Segmentation, Targeting and Positioning (STP) Analysis
- Molnlycke Health Care AB Ansoff Matrix Analysis
Table of Contents
Table of Contents 2
Tables 5
Charts 6
Molnlycke Health Care AB - Key Company Facts 7
Molnlycke Health Care AB - Company Description 8
Molnlycke Health Care AB - Top Executives 9
Molnlycke Health Care AB - Head Office & Locations 10
Head Office - Country 10
Molnlycke Health Care AB - Products and Services 11
Products 11
Services 12
Molnlycke Health Care AB - Corporate Strategy 13
Molnlycke Health Care AB - Business Description 16
Wound Care 16
Operating Room Solutions 17
Gloves 18
Antiseptics 18
Molnlycke Health Care AB - ESG Spotlight 19
Environment 19
Social 20
Corporate Governance 20
Molnlycke Health Care AB - SWOT Analysis 21
Overview 21
Strengths 23
Weaknesses 25
Opportunities 27
Threats 29
Competing Players 31
Snapshot of Competing Players 32
Coloplast AS 32
Key Company Facts 32
Company Description 32
Key Financials 33
Share Price Trend - Jan-2024 to Jun-2025 (Average Share Closing Price) 33
Key Financial Ratio Analysis 38
ConvaTec Group Plc 39
Key Company Facts 39
Company Description 39
Key Financials 40
Share Price Trend - Jan-2024 to Jun-2025 (Average Share Closing Price) 40
Key Financial Ratio Analysis 45
Smith & Nephew Plc 46
Key Company Facts 46
Company Description 46
Smith & Nephew Plc - SWOT Spotlight 47
Smith & Nephew Plc - PESTLE Spotlight 49
Key Financials 51
Share Price Trend - Jan-2024 to Jun-2025 (Average Share Closing Price) 51
Key Financial Ratio Analysis 56
B. Braun SE 57
Key Company Facts 57
Company Description 57
Medline Industries LP 58
Key Company Facts 58
Company Description 58
Molnlycke Health Care AB - In the News 59
21-May-2025- Molnycke Health Care inaugurates new global headquarters at GoCo Health Innovation City 59
13-May-2025- Molnlycke Health Care's long-term target to reach net zero emissions validated by Science Based Targets initiative 61
01-Apr-2025- Molnlycke Health Care publishes Annual report for 2024 61
28-Mar-2025- New study demonstrates the potential benefits of dressing regime improvements in delivering value-based chronic wound care 63
25-Feb-2025- Molnlycke Health Care announces launch of the 2025 Future Summit 65
29-Jan-2025- Molnlycke Health Care reaches 100% renewable electricity target 66
08-Jan-2025- Molnlycke Health Care announces USD 8 million investment in diabetic foot ulcer management system company Siren 67
26-Nov-2024- Molnycke Health Care wins Swedish Sustainability Tech award 68
15-May-2024- Tamer Molnlycke Care joint venture 68
13-Apr-2024- Molnlycke agrees to acquire leading wound cleansing manufacturer to consolidate its position as global leader in wound care 69
20-Mar-2024- Molnlycke awarded a gold medal for sustainability 70
Appendix 71
Definitions 71
SWOT Analysis 71
PESTLE Analysis 71
Value Chain Analysis 71
ESG Spotlight 71
Research Methodology 72
Disclaimer 73
Contact Us 73
Tables
Table 1: Molnlycke Health Care AB - Company Facts
Table 2: Molnlycke Health Care AB - Digital Presence
Table 3: Molnlycke Health Care AB - Top Executives
Table 4: Molnlycke Health Care AB - Products
Table 5: Molnlycke Health Care AB - Services
Table 6: Molnlycke Health Care AB -Competing Players
Table 7: Competing Players - Coloplast AS - Key Company Facts
Table 8: Coloplast AS - Share Price Trend - Jan-2024 to Jun-2025
Table 9: Competing Players - Coloplast AS - Profit and Loss Statement
Table 10: Coloplast AS - Balance Sheet 2021-2024
Table 11: Coloplast AS - Cash Flow Statement 2021-2024
Table 12: Coloplast AS - Ratio Analysis - 2021-2024
Table 13: Competing Players - ConvaTec Group Plc - Key Company Facts
Table 14: ConvaTec Group Plc - Share Price Trend - Jan-2024 to Jun-2025
Table 15: Competing Players - ConvaTec Group Plc - Profit and Loss Statement
Table 16: ConvaTec Group Plc - Balance Sheet 2021-2024
Table 17: ConvaTec Group Plc - Cash Flow Statement 2021-2024
Table 18: ConvaTec Group Plc - Ratio Analysis - 2020-2023
Table 19: Competing Players - Smith & Nephew Plc - Key Company Facts
Table 20: Smith & Nephew Plc - Share Price Trend - Jan-2024 to Jun-2025
Table 21: Competing Players - Smith & Nephew Plc - Profit and Loss Statement
Table 22: Smith & Nephew Plc - Balance Sheet 2021-2024
Table 23: Smith & Nephew Plc - Cash Flow Statement 2021-2024
Table 24: Smith & Nephew Plc - Ratio Analysis - 2020-2023
Table 25: Competing Players - B. Braun SE - Key Company Facts
Table 26: Competing Players - Medline Industries LP - Key Company Facts
Charts
Figure 1: Molnlycke Health Care AB - SWOT Analysis
Figure 2: Coloplast AS - Average Share Price Trend -Jan-2024 to Jun-2025
Figure 3: Coloplast AS - Profit and Loss Statement - 2021-2024
Figure 4: Coloplast AS - Balance Sheet - 2021-2024
Figure 5: Coloplast AS - Cash Flow Statement 2021-2024
Figure 6: ConvaTec Group Plc - Average Share Price Trend -Jan-2024 to Jun-2025
Figure 7: ConvaTec Group Plc - Profit and Loss Statement - 2021-2024
Figure 8: ConvaTec Group Plc - Balance Sheet - 2021-2024
Figure 9: ConvaTec Group Plc - Cash Flow Statement 2021-2024
Figure 10: Competing Players - Smith & Nephew Plc - SWOTSpotlight
Figure 11: Competing Players - Smith & Nephew Plc - PESTLE Spotlight
Figure 12: Smith & Nephew Plc - Average Share Price Trend -Jan-2024 to Jun-2025
Figure 13: Smith & Nephew Plc - Profit and Loss Statement - 2021-2024
Figure 14: Smith & Nephew Plc - Balance Sheet - 2021-2024
Figure 15: Smith & Nephew Plc - Cash Flow Statement 2021-2024
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.